Full-service CRO CER Groupe offers preclinical, analytical, and bioproduction services under strict quality standards (GLP, ISO 9001, ISO 17025, NRL), presenting a one-stop solution for pharma, biotech, and diagnostics companies seeking end-to-end early-stage development and compliant testing.

Clinical and Agriculture Synergy The company serves both human health and agricultural sectors, including diagnostics kits and polyclonal/monoclonal antibodies, enabling cross-sector selling opportunities to biotech firms expanding into animal and plant health markets.

Walloon Regional Focus Located in the Walloon Region of Belgium and integrated in the regional biotech network, CER Groupe can leverage local grants, partnerships, and policy programs to accelerate joint ventures, sponsored research, and funded projects with academic and industry partners.

Accreditation Advantage Accreditations and laboratory standards position CER Groupe as a trusted partner for regulated studies, enabling contract opportunities with clients requiring GLP and ISO-compliant testing, as well as potential collaborations for national reference laboratory activities.

Mid-market Growth With a mid-sized employee base and revenue between one and ten million, CER Groupe is an attractive target for scalable outsourcing partnerships, early-stage program support, and expansion into international clients seeking flexible, quality-focused CRO capabilities.